- Coronavirus - Covid19, Drug development, Infectious disease, Medicine, Medicine & Politics, Public health
Coronavirus Tidbits #48 5/17/20
Quick links News Diagnostics Drugs Devices Epidemiology/Infection control Tips Politics Feel good du jour Comic relief Perspective/Poem Bits of beauty Announcements: First, there is now a Resources Page here for the most commonly asked questions I’m getting. Tidbits will likely be a bit shorter and a little less frequent for the next little bit. Read more
-
Coronavirus Tidbits # 19 3-26-20
News: This is very exciting to me and the best news of the day. I met David Fajgenbaum at a conference to launch CURE ID, the Drug Repurposing program I’ve been excited about. Go watch this video, starting at ~3:42:14 of his remarkable story. He’s translated that drive into #COVID19 research now and his team has done remarkable work extracting data in just 6 days! Read more
-
Coronavirus tidbits # 18 3-25-20
News: One doctor’s straight talk about the coronavirus strikes a chord with anxious Americans This is an excellent, very short clip. Highly recommended Emily Landon https://www.washingtonpost.com/health/2020/03/20/emily-landon-coronavirus/ Perspective: The coronavirus economic downfall will affect those who can least afford it https://www.zmescience.com/science/the-coronavirus-economic-downfall-will-affect-those-who-can-least-afford-it/ Why you should stay at home: My friend Shira is a superstar with her advocacy for patients with #RareDiseases, and is the founder of Sick Chicks. Read more
-
From the Holocaust to Thalidomide: A Nazi Legacy
Although thalidomide, a drug first sold for morning sickness, was released in 1957, the heartbreak from its damage continues and lessons have not yet been learned—including the need for better research and corporate ethics, the need to care for those hurt by an “advance,” and the importance of strong and ethical oversight from government regulators like Frances Kelsey, the FDA reviewer who prevented the birth defects caused by thalidomide from occurring in the United States by blocking its approval. Read more
